Corporate Overview – Ruifeng Chem (300243.SZ)
Trading Activity
Ruifeng Chem closed at the same price it opened on Friday, 23 November 2026, with a 0 % change over the 24‑hour period ending 20:07 CET.
The current trading price is CNY 17.71 per share on major exchanges.
Market Metrics
Shares Outstanding: 294.2 million.
Market Capitalisation: CNY 5.4 billion.
Daily Trading Volume (last 24 h): CNY 761.8 million worth of shares exchanged.
Price Performance: Down 25.84 % since the end of the previous month.
200‑Day Simple Moving Average: CNY 17.56.
52‑Week High/Low: Highest price was CNY 24.96 on 23 September 2026; lowest price was CNY 9.75 on 17 December 2025.
Peer Performance – 24‑Hour Summary
| Stock | Symbol | 24‑Hour Change | Current Price | Market Capitalisation | P/E Ratio |
|---|---|---|---|---|---|
| Huanlejia Food Ltd. | 300997.SZ | 0 % | CNY 15.21 | CNY 6.4 billion | 133.44 |
| Miracle Automation Enginee | 002009.SZ | 0 % | CNY 17.30 | CNY 6.4 billion | 141.84 |
| Shenzhen Dobot -H | 2432.HK | -6.49 % | HKD 17.04 | HKD 7.5 billion | – |
| Xiangyu Medical | 688626.SS | 0 % | CNY 42.42 | CNY 6.4 billion | 77.65 |
| Xingye Tech | 002674.SZ | 0 % | CNY 21.47 | CNY 6.4 billion | 52.71 |
Detailed Notes on Selected Peers
Miracle Automation Enginee
Shares remained flat within a narrow price range during the trading day, indicating stable supply‑demand dynamics.
Trading volume increased, reflecting heightened investor interest.
No significant corporate events or regulatory actions were reported.
Xingye Tech
Announced the acquisition of indium phosphide substrate assets for 55 million yuan, aiming to enter the semiconductor and optical‑communication sector.
The acquisition initially caused a rapid rise in the share price, reaching a record high.
A regulatory notice from the China Securities Regulatory Commission followed, citing alleged information‑disclosure violations.
The company maintains that core operations are unaffected.
Analysts highlight concerns over the valuation of the acquired assets and the target’s loss‑making status.
Financial indicators show rising accounts receivable and inventory, declining operating cash flow, and reduced liquid assets.
The regulatory inquiry and acquisition uncertainties have contributed to a pullback from previous highs.
The information presented reflects the latest trading data and corporate disclosures available up to 23 November 2026.
